A multicenter, randomized, open-labelled, non-inferiority trial of sustained-release sarpogrelate versus clopidogrel after femoropopliteal artery intervention

Optimal antiplatelet therapy after endovascular therapy (EVT) for peripheral artery disease is controversial. This trial aimed to evaluate whether sarpogrelate plus aspirin was non-inferior for preventing early restenosis after femoropopliteal (FP) EVT compared to clopidogrel plus aspirin. In this o...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Ahram, Lee, Taeseung, Lee, Joongyub, Song, Suk-Won, Lee, Sang-Su, Jung, In Mok, Kang, Jin Mo, Gwon, Jun Gyo, Yun, Woo-Sung, Cho, Yong-Pil, Ko, Hyunmin, Park, Yang-Jin, Min, Seung-Kee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925771/
https://www.ncbi.nlm.nih.gov/pubmed/36781928
http://dx.doi.org/10.1038/s41598-023-29006-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925771/
https://www.ncbi.nlm.nih.gov/pubmed/36781928
http://dx.doi.org/10.1038/s41598-023-29006-z

Ejemplares similares